CA2062900A1 - Saliva testing and fingerprint identification method and device - Google Patents

Saliva testing and fingerprint identification method and device

Info

Publication number: CA2062900A1
Authority: CA; Canada
Prior art keywords: saliva; testing; membrane; test subject; substances
Prior art date: 1991-03-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2062900

Other languages

English (en)

French (fr)

Inventor

Raouf A. Guirguis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

La Mina Ltd

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-12

Filing date

1992-03-12

Publication date

1992-09-13

1992-03-12 Application filed by Individual filed Critical Individual

1992-09-13 Publication of CA2062900A1 publication Critical patent/CA2062900A1/en

Status Abandoned legal-status Critical Current

Links

238000012360 testing method Methods 0.000 title claims abstract description 82
210000003296 saliva Anatomy 0.000 title claims abstract description 67
238000000034 method Methods 0.000 title claims abstract description 26
239000012528 membrane Substances 0.000 claims abstract description 58
239000000427 antigen Substances 0.000 claims abstract description 39
102000036639 antigens Human genes 0.000 claims abstract description 39
108091007433 antigens Proteins 0.000 claims abstract description 39
239000000126 substance Substances 0.000 claims abstract description 34
239000003814 drug Substances 0.000 claims abstract description 33
229940079593 drug Drugs 0.000 claims abstract description 32
239000002250 absorbent Substances 0.000 claims abstract description 9
230000002745 absorbent Effects 0.000 claims abstract description 9
210000001589 microsome Anatomy 0.000 claims abstract description 6
238000010998 test method Methods 0.000 claims abstract description 6
239000010409 thin film Substances 0.000 claims abstract description 3
ZPUCINDJVBIVPJ-LJISPDSOSA-N ***e Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims description 18
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 18
239000003446 ligand Substances 0.000 claims description 13
241000282414 Homo sapiens Species 0.000 claims description 11
229910052737 gold Inorganic materials 0.000 claims description 11
239000010931 gold Substances 0.000 claims description 11
229960003920 ***e Drugs 0.000 claims description 9
238000006243 chemical reaction Methods 0.000 claims description 8
238000003556 assay Methods 0.000 claims description 7
239000002245 particle Substances 0.000 claims description 7
239000004033 plastic Substances 0.000 claims description 7
229920003023 plastic Polymers 0.000 claims description 7
229910052709 silver Inorganic materials 0.000 claims description 7
239000004332 silver Substances 0.000 claims description 7
229960001252 methamphetamine Drugs 0.000 claims description 4
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims description 4
229940127240 opiate Drugs 0.000 claims description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
230000005764 inhibitory process Effects 0.000 claims description 3
125000003636 chemical group Chemical group 0.000 claims description 2
238000003825 pressing Methods 0.000 claims description 2
239000002131 composite material Substances 0.000 claims 3
241000282412 Homo Species 0.000 claims 2
239000004005 microsphere Substances 0.000 claims 2
238000012800 visualization Methods 0.000 claims 1
238000002156 mixing Methods 0.000 abstract description 2
102000004169 proteins and genes Human genes 0.000 description 28
108090000623 proteins and genes Proteins 0.000 description 28
230000027455 binding Effects 0.000 description 20
102000004190 Enzymes Human genes 0.000 description 14
108090000790 Enzymes Proteins 0.000 description 14
239000000758 substrate Substances 0.000 description 12
238000001514 detection method Methods 0.000 description 10
210000003811 finger Anatomy 0.000 description 10
239000012530 fluid Substances 0.000 description 10
239000000243 solution Substances 0.000 description 10
239000003593 chromogenic compound Substances 0.000 description 9
239000004816 latex Substances 0.000 description 9
229920000126 latex Polymers 0.000 description 9
239000000020 Nitrocellulose Substances 0.000 description 8
229920001220 nitrocellulos Polymers 0.000 description 8
238000002965 ELISA Methods 0.000 description 6
229910019142 PO4 Inorganic materials 0.000 description 6
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
235000021317 phosphate Nutrition 0.000 description 6
238000003018 immunoassay Methods 0.000 description 5
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
239000010452 phosphate Substances 0.000 description 5
239000004677 Nylon Substances 0.000 description 4
238000002372 labelling Methods 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
229920001778 nylon Polymers 0.000 description 4
102000013415 peroxidase activity proteins Human genes 0.000 description 4
108040007629 peroxidase activity proteins Proteins 0.000 description 4
239000000376 reactant Substances 0.000 description 4
210000002700 urine Anatomy 0.000 description 4
230000000903 blocking effect Effects 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
229960005181 morphine Drugs 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
238000001179 sorption measurement Methods 0.000 description 3
210000003813 thumb Anatomy 0.000 description 3
231100000027 toxicology Toxicity 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
CXNVOWPRHWWCQR-UHFFFAOYSA-N 4-Chloro-ortho-toluidine Chemical compound CC1=CC(Cl)=CC=C1N CXNVOWPRHWWCQR-UHFFFAOYSA-N 0.000 description 2
QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
238000011161 development Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
238000003255 drug test Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
229920002981 polyvinylidene fluoride Polymers 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
XVARCVCWNFACQC-MBJXGIAVSA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-(1h-indol-3-yloxy)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=CC=C12 XVARCVCWNFACQC-MBJXGIAVSA-N 0.000 description 1
QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
HOQAPVYOGBLGOC-UHFFFAOYSA-N 1-ethyl-9h-carbazole Chemical compound C12=CC=CC=C2NC2=C1C=CC=C2CC HOQAPVYOGBLGOC-UHFFFAOYSA-N 0.000 description 1
VMXLZAVIEYWCLQ-UHFFFAOYSA-N 4-(4-aminophenyl)-3-methylaniline Chemical compound CC1=CC(N)=CC=C1C1=CC=C(N)C=C1 VMXLZAVIEYWCLQ-UHFFFAOYSA-N 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
JIEINYQEXWLMCU-UHFFFAOYSA-N 7-bromo-3-hydroxy-n-(2-methoxyphenyl)naphthalene-2-carboxamide Chemical compound COC1=CC=CC=C1NC(=O)C1=CC2=CC(Br)=CC=C2C=C1O JIEINYQEXWLMCU-UHFFFAOYSA-N 0.000 description 1
235000011330 Armoracia rusticana Nutrition 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
-1 Bromochloroindolyl Chemical group 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
101710101803 DNA-binding protein J Proteins 0.000 description 1
GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000000386 athletic effect Effects 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
229920005601 base polymer Polymers 0.000 description 1
239000011324 bead Substances 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
239000003124 biologic agent Substances 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
102000043871 biotin binding protein Human genes 0.000 description 1
108700021042 biotin binding protein Proteins 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229960004126 codeine Drugs 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
238000000151 deposition Methods 0.000 description 1
229960001985 dextromethorphan Drugs 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
229960002069 diamorphine Drugs 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
229940127121 immunoconjugate Drugs 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000007373 indentation Methods 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
UMTMDKJVZSXFNJ-UHFFFAOYSA-N nickel;trihydrate Chemical compound O.O.O.[Ni] UMTMDKJVZSXFNJ-UHFFFAOYSA-N 0.000 description 1
JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002357 osmotic agent Substances 0.000 description 1
235000020030 perry Nutrition 0.000 description 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
238000003118 sandwich ELISA Methods 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000002791 soaking Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
210000003670 sublingual gland Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0009—Testing for drug or alcohol abuse

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA 2062900 1991-03-12 1992-03-12 Saliva testing and fingerprint identification method and device Abandoned CA2062900A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66811591A	1991-03-12	1991-03-12
US07/668,115		1991-03-12

Publications (1)

Publication Number	Publication Date
CA2062900A1 true CA2062900A1 (en)	1992-09-13

Family

ID=24681079

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2062900 Abandoned CA2062900A1 (en)	1991-03-12	1992-03-12	Saliva testing and fingerprint identification method and device

Country Status (4)

Country	Link
EP (1)	EP0637383A1 (de)
AU (1)	AU1589092A (de)
CA (1)	CA2062900A1 (de)
WO (1)	WO1992016842A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19647545A1 (de)	1996-11-16	1998-05-20	M & M Dental Medizin Gmbh	Verwendung zum Bestimmen des Kariesrisikos und dazu besonders geeignete Testeinrichtung
EP0860701A1 (de) *	1997-02-19	1998-08-26	"The Ultimate" Pharma et Health Products GmbH	Teststrip combination
WO1998044158A1 (en) *	1997-03-28	1998-10-08	Epitope, Inc.	Simultaneous collection of dna and non-nucleic analytes from oral fluids
WO2002053030A1 (fr) *	2001-01-05	2002-07-11	Ovulex, Inc.	Procede et dispositif pour evaluer l'etat physiologique de l'organisme humain
US7114403B2 (en)	2003-05-30	2006-10-03	Oakville Hong Kong Co., Ltd	Fluid collection and application device and methods of use of same
US20050135964A1 (en) *	2003-12-22	2005-06-23	Ulrich Sieben	Carrier medium for analyzing a substance
CN1853103A (zh) *	2003-08-19	2006-10-25	迈克纳斯公司	用于分析物质的载体元件
JP4253344B2 (ja)	2003-11-14	2009-04-08	インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング	封止可能なサンプル保存リザーバを備える流体サンプル分析装置
JP2009524799A (ja)	2005-11-30	2009-07-02	インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング	流体試料中の分析物の存在または量を検出するための装置およびその方法
US11906512B2 (en)	2006-03-31	2024-02-20	Zeus Diagnostics, LLC	Integrated device for analyte testing, confirmation, and donor identity verification
US8940527B2 (en)	2006-03-31	2015-01-27	Lamina Equities Corp.	Integrated device for analyte testing, confirmation, and donor identity verification
US7879623B2 (en)	2006-03-31	2011-02-01	Guirguis Raouf A	Integrated device for analyte, testing, confirmation, and donor identity verification
US7741103B2 (en) *	2006-03-31	2010-06-22	Guirguis Raouf A	Integrated screening and confirmation device
DE212007000054U1 (de)	2006-07-26	2009-03-19	Abon Biopharm Hangzhou	Testvorrichtung zum Nachweisen eines Analyten in einer flüssigen Probe
WO2013006391A1 (en) *	2011-07-01	2013-01-10	3M Innovative Properties Company	A method and apparatus for screening drug offenders
US10433787B2 (en)	2014-07-07	2019-10-08	3M Electronic Monitoring Ltd	Self-administered tamper-evident drug detection
US10564155B2 (en)	2017-01-27	2020-02-18	Raouf A Guirguis	Dual swab fluid sample collection for split sample testing and fingerprint identification device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4963325A (en) *	1988-05-06	1990-10-16	Hygeia Sciences, Inc.	Swab expressor immunoassay device
ATE157456T1 (de) *	1990-01-19	1997-09-15	Mina Ltd	Gerät und verfahren zur untersuchung von blut und zur fingerabdruck-identifikation

1992
- 1992-03-12 WO PCT/US1992/001793 patent/WO1992016842A1/en not_active Application Discontinuation
- 1992-03-12 EP EP92908425A patent/EP0637383A1/de not_active Withdrawn
- 1992-03-12 AU AU15890/92A patent/AU1589092A/en not_active Abandoned
- 1992-03-12 CA CA 2062900 patent/CA2062900A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU1589092A (en)	1992-10-21
EP0637383A1 (de)	1995-02-08
WO1992016842A1 (en)	1992-10-01
EP0637383A4 (de)	1994-07-01

Legal Events

Date	Code	Title	Description
1995-09-12	FZDE	Dead

Publication	Publication Date	Title
US5244815A (en)	1993-09-14	Fingerprint test pad and method for fingerprinting using particle based immunoassay
JP4040110B2 (ja)	2008-01-30	膜ベースでの検定のための分析装置
US7666614B2 (en)	2010-02-23	Method of use of one step immunochromatographic device for Streptococcus A antigen
EP0465266B1 (de)	1995-12-13	Immunoassay mit komplementärem sichtbaren Signal
US7060505B2 (en)	2006-06-13	Assay device
CA2062900A1 (en)	1992-09-13	Saliva testing and fingerprint identification method and device
EP0480497B1 (de)	1996-10-23	Vorrichtung zur Durchführung einer raschen einfachen Handprüfung
US20030045001A1 (en)	2003-03-06	Immunochromatographic test strip with arcuate sample application zone for ease-of-use in the field
AU2006321289A1 (en)	2007-06-07	Two step lateral flow assay methods and devices
JP2004538453A (ja)	2004-12-24	全細胞を含有するサンプルに対するラテラルフローアッセイのための試験片
JPS5876763A (ja)	1983-05-09	抗原の存在を検出する方法及びこれに用いる装置
EP0440350B1 (de)	1997-08-27	Gerät und Verfahren zur Untersuchung von Blut und zur Fingerabdruck-Identifikation
AU2005212666A1 (en)	2005-08-25	Sampling device, the method and use thereof
GB2199946A (en)	1988-07-20	Diagnostic device,
NZ521712A (en)	2004-04-30	Device for detecting analytes related to saliva sample pH for measuring drug concentration in blood
JP3529096B2 (ja)	2004-05-24	アッセイ装置
JPS63210664A (ja)	1988-09-01	酸素要求検出系を用いる装置のための乾燥試験片及び被検流体中の分析成分の検出方法